Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych CASC / OSCEPsychopharmacology — rTMS, VNS and DBS

Psych CASC / OSCE · Psychopharmacology — rTMS, VNS and DBS

Explaining rTMS vs implants vs ECT for TRD (CASC)

CASC-style communication station: shared decision on rTMS first for outpatient TRD, honest VNS/DBS evidence, ECT comparator, safety and realistic expectations.

communication
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 48-year-old man with treatment-resistant depression and his partner ask about 'TMS magnets', 'the vagus pacemaker', and 'deep brain electrodes'. They fear ECT memory loss, want a guaranteed cure, and wonder if implants are better because they are 'more high-tech'.

Station instructions (candidate)

You have 7 minutes. Explain why, after several adequate antidepressant failures, rTMS/iTBS is a reasonable next outpatient option: how sessions work (daily weeks; optional shorter iTBS), common side effects (scalp discomfort, headache; rare seizure), need for safety screening, and realistic response rates — not a guaranteed cure. Briefly place VNS (implant, delayed benefit, mixed acute RCT vs longer-term data) and DBS (specialist research; major controlled trials for key targets did not meet primary endpoints) so 'more invasive' is not sold as 'more proven'. Compare with ECT without stigma theatre: ECT remains important for more severe or urgent presentations and for some who do not respond to rTMS. Check understanding; invite questions; offer written information and crisis contacts.[1][2][3][4][5][6]

Marking domains

Empathy and agenda; accurate plain-language TRD rationale; clear rTMS process and AE; no cure promises; honest implant evidence hierarchy; balanced ECT comparison; collaborative plan and safety netting.[1][2][5][6]

Model communication map

  1. Open: thank them; check what they already know about magnets/implants/ECT; name shared goals (mood, function, safety).[6]
  2. Why now: several proper medicine trials have not controlled depression; outpatient brain stimulation with a magnetic coil (rTMS) has randomised evidence for people in this situation.[1][6]
  3. How rTMS works: awake outpatient sessions, usually most weekdays for about 4–6 weeks; we measure a motor threshold to set a safe personal intensity; some clinics use a shorter burst pattern (iTBS) that trials found not worse than standard sessions.[1][2]
  4. What he may feel: scalp tapping/discomfort or headache are common and usually settle; seizures are uncommon but we screen risk and stop if one occurs.[1]
  5. Implants: a vagus nerve stimulator is surgery with benefits that may build over months; the short sham-controlled study was disappointing on its main measure, while longer observational comparisons look more hopeful — not a quick fix.[3][4] Deep brain electrodes are highly specialised; important controlled trials for major depression targets did not prove clear benefit on primary outcomes — we would only discuss that later at a specialist centre if needed.[5]
  6. ECT: not outdated stigma care; for more severe illness (psychosis, catatonia, or when speed is critical) it can still be the most reliable option; modern techniques reduce — not eliminate — cognitive side effects. Choosing rTMS now does not ban future ECT if needed.[6]
  7. Close: questions, written info, session logistics, crisis contacts, partner support role, follow-up review of scores.[6]

Common fails

  • Guaranteeing permanent cure from rTMS or implants.[1][6]
  • Saying DBS is routine and proven after failed tablets.[5]
  • Claiming VNS acute sham trial was a clear primary success.[3]
  • Dismissing ECT as obsolete or cruel without nuance.[6]
  • Skipping safety screen explanation (metal, seizures).[1]

References

  1. [1]O'Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial Biol Psychiatry, 2007.PMID 17573044
  2. [2]Blumberger DM, Vila-Rodriguez F, Thorpe KE, et al. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial Lancet, 2018.PMID 29726344
  3. [3]Rush AJ, Marangell LB, Sackeim HA, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial Biol Psychiatry, 2005.PMID 16139580
  4. [4]Aaronson ST, Sears P, Ruvuna F, et al. A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality Am J Psychiatry, 2017.PMID 28359201
  5. [5]Holtzheimer PE, Husain MM, Lisanby SH, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial Lancet Psychiatry, 2017.PMID 28988904
  6. [6]Milev RV, Giacobbe P, Kennedy SH, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments Can J Psychiatry, 2016.PMID 27486154